SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001618835-19-000176
Filing Date
2019-11-18
Accepted
2019-11-18 17:30:54
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 evfms-3shelfregistration.htm S-3 548218
2 EXHIBIT 1.2 exhibit12atmequitydistribu.htm EX-1.2 286560
3 EXHIBIT 4.4 exhibit44formofseniorinden.htm EX-4.4 476530
4 EXHIBIT 4.5 exhibit45formofsubordinate.htm EX-4.5 433291
5 EXHIBIT 5.1 exhibit51mintzopnion.htm EX-5.1 39244
6 EXHIBIT 23.1 exhibit231-deloitteconsent.htm EX-23.1 3398
7 evofembiosciencesjpegfilea25.jpg GRAPHIC 61097
8 evofembiosciencesjpegfilea26.jpg GRAPHIC 61097
9 mintza19.jpg GRAPHIC 8872
  Complete submission text file 0001618835-19-000176.txt   1968871
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234769 | Film No.: 191228482
SIC: 2834 Pharmaceutical Preparations